KC
Congress trade
Rep. Katherine Clark (D-MA) sold $1K-$15K of Merck & Company, Inc. (MRK) stock
Katherine Clark, U.S. Representative (D-MA), disclosed a sale of Merck & Company, Inc. (MRK) stock worth $1K-$15K in a STOCK Act filing on Oct 14, 2021.
The trade happened on Sep 16, 2021, 28 days before it was made public.
MRK has moved +102.8% since the trade date, from $71.97 to $145.95 (Oct 16, 2026 close).
- Traded
- Sep 16, 2021
- Disclosed
- Oct 14, 2021
- Filing delay
- 28 days
- Price since
- +102.8%
- Source
- STOCK Act disclosure
Other trades in this disclosure (26)
- SellFSLR$15K-$50KOct 14, 2021
- SellAY$1K-$15KOct 14, 2021
- SellBBY$1K-$15KOct 14, 2021
- SellCCEP$1K-$15KOct 14, 2021
- SellCLNE$1K-$15KOct 14, 2021
- SellCSCO$1K-$15KOct 14, 2021
- SellEW$1K-$15KOct 14, 2021
- SellGOOGL$1K-$15KOct 14, 2021
- SellHD$1K-$15KOct 14, 2021
- SellHON$1K-$15KOct 14, 2021
- SellINTC$1K-$15KOct 14, 2021
- SellMA$1K-$15KOct 14, 2021
- SellMSFT$1K-$15KOct 14, 2021
- SellNVO$1K-$15KOct 14, 2021
- SellORCL$1K-$15KOct 14, 2021
- SellPEP$1K-$15KOct 14, 2021
- SellPHG$1K-$15KOct 14, 2021
- SellSAP$1K-$15KOct 14, 2021
- SellSBUX$1K-$15KOct 14, 2021
- SellSONY$1K-$15KOct 14, 2021
More MRK insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.